Technical Feasibility Study on Screening Sleep Related Breathing Disturbances and Sleep Apnoea With Wearable Sensors
NCT ID: NCT05235984
Last Updated: 2023-10-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2022-07-18
2023-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
SLEEPINESS - a Search for a Biomarker of Excessive Daytime Sleepiness in Severe Obstructive Sleep Apnoea - An Explorative Study
NCT06711159
Portable System for Non-intrusive Monitoring of Sleep
NCT06029881
Comparison of SomnaPatch With Polysomnography in Sleep Disordered Breathing
NCT02034175
Screening for Sleep Disordered Breathing With Minimally Obtrusive Sensors
NCT02470182
Contactless Detection of Sleep Apnea
NCT04670848
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinical reason i.e. potential benefit of repeating the PG due to e.g. technical challenges in the previous PG and/or unclear findings or diagnosis. Participation may be offered also in cases where first PG is diagnostic. In these cases accuracy of sleep apnoea grading will be improved.
* Adequate Finnish language skills to comprehend study-related instructions and questionnaires. The study materials are available only in Finnish.
* Signed written informed consent
Exclusion Criteria
* Use of cardiac pacemaker or history of atrial fibrillation
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CSEM Centre Suisse d'Electronique et de Microtechnique SA - Recherche et Developpement
INDUSTRY
Firstbeat Technologies Oy
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Juha K Heiskala, LM, DSc
Role: STUDY_DIRECTOR
Neurophysiologist at HUS (Hospital district of Helsinki and Uusimaa) and at KNF-Laboratoriot Oy
Ilkka Korhonen, DSc
Role: PRINCIPAL_INVESTIGATOR
CTO at Firstbeat Technologies and Associate Professor at Tampere University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
KNF-Laboratoriot Oy
Helsinki, Southern Finland, Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Screenbeat_SA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.